Incidence of 106TBL Lymph Node Metastasis
Recruiting
Observational Study
Esophageal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 – 85
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,852 (estimated)
- Sponsor
- Fudan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
the study was to document the incidence of left tracheobronchial lymph node metastasis, and the risk factors of metastasis.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with esophageal squamous cell carcinoma
* clinical staging: cT1-4a N0/+ M0.
* no history of other malignancy.
Exclusion Criteria:
* esophageal cancer in the neck
* poor physical status to have esophagectomy.
Contacts